NCT04223349View on ClinicalTrials.gov

A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

April 8, 2020

Study Completion Date

April 8, 2020

Conditions
Healthy
Interventions
DRUG

JNJ-70033093

JNJ-70033093 capsules will be administered orally .

DRUG

Placebo

Matching placebo in capsule will be administered orally.

Trial Locations (1)

84124

PRA Health Sciences, Salt Lake City

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04223349 - A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants | Biotech Hunter | Biotech Hunter